By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Neurotrope 

10732 Hawk’s Vista Street

Plantation  Florida  33324  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS



Segment
Start Up





Company News
Neurotrope Announces Last Patient Dosed In Phase 2a Clinical Trial Of Bryostatin-1 For Alzheimer’s Disease 11/20/2014 11:45:18 AM
Neurotrope Announces Last Patient Dosed In Phase 2a Clinical Trial Of Bryostatin-1 For Alzheimer's Disease 11/20/2014 9:53:18 AM
Neurotrope Appoints Warren W. Wasiewski, M.D. As Executive Vice President, Development And Chief Medical Officer 11/6/2014 9:01:18 AM
Larry D. Altstiel, M.D., Ph.D. Joins Neurotrope Board Of Directors 9/18/2014 9:32:27 AM
Neurotrope To Host Conference Call 8/21/2014 7:53:37 AM
Neurotrope Initiates Phase 2a Study Of Bryostatin For The Treatment Of Alzheimer's Disease - Doses First Patients 7/29/2014 8:12:19 AM
Neurotrope Enters Collaborative Agreement With Icahn School Of Medicine At Mount Sinai For Use Of Bryostatin-1 In The Treatment Of Niemann-Pick Disease Type C 7/22/2014 7:09:59 AM
Neurotrope Board Of Directors Appoints Chairmen Ramat And Freiman As Interim Co-CEOs 7/18/2014 11:53:01 AM
Neurotrope Appoints Charles S. Ramat And Paul Freiman As Co-Chairmen Of The Board 6/19/2014 7:41:59 AM
Neurotrope Appoints Neuroscientist Sam Kongsamut As Executive Director, Pharmacology 6/4/2014 7:27:48 AM
12
//-->